Search Results 701-710 of 17000 for Hepatotoxicity
Prostate Cancer Risk Prediction Model Using Clinical and Magnetic Resonance Imaging-Related Findings: Impact of Combining Lesions' Locations and Apparent ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Marla Broadfoot, Ph.D. April 6, 2026. Mayo Clinic experimental dual-drug nanotherapy crosses the blood-brain barrier and improved survival.
albicans to dysbiotic microbial communities of mucosal tissues in pediatric populations. Prospective sampling across multiples tissue sites in a pediatric ...
Mayo researchers, minority communities team up to combat COVID-19 health disparities featured image · Early indicators: Investigational convalescent plasma is ...
This study evaluates the safety and tolerability of extended dosing with ISIS-TTR Rx in patients with Familial Amyloid Polyneuropathy. Participation eligibility.
If stomach acid washes back into the esophagus, it can cause discomfort and may lead to precancerous changes in the lining of the esophagus.
Because the heart and liver are closely linked, an electrocardiogram (ECG) can capture electrical signal changes in the heart connected to advanced liver ...
The aim of this study is to describe management and outcomes (subjective function, return to play, complications) of competitive wrestlers presenting with Morel ...
This study will evaluate the effectiveness, safety, and tolerability of GS-5745. It will consist of 2 parts: Induction Study (Cohort 1) and Maintenance Study ( ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!